Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


With EU Notified Body Numbers Tumbling, How Do Manufacturers Ensure Seamless Transition To MDR?

Executive Summary

Device manufacturers in the EU are beginning to realize the extra volume of MDR/IVDR-related work that their pivotal market access partners, the notified bodies, will have to take on. With the regulations' three- and five-year transition period clocks ticking down already, manufacturers must make sure that business continuity is guaranteed – but it won't be easy.


Related Content

EU Medtech Ecosystem Will Suffer Unless Notified Body Workload Concerns Are Addressed – The German View
EU MDR Set To Rack Up Costs For Industry, German Medtechs Say
UK Medtech One Year Post-Brexit Vote: Still In The Land of Uncertainty
EU Notified Bodies 'Under Pressure And Scared'
UK Being Edged Toward The EU's Back Door – Is It So Simple?





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts